Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,273 | -46,284 | 53,815 | -38,463 | N/A |
| Depreciation Amortization | 3,775 | 1,201 | 1,097 | 1,188 | N/A |
| Accounts receivable | -5,043 | -11 | 44 | 284 | N/A |
| Other Working Capital | 5,675 | -3,212 | 188 | 5,853 | N/A |
| Other Operating Activity | 29,917 | 1,107 | -91,329 | -1,406 | 0 |
| Operating Cash Flow | $-57,949 | $-47,199 | $-36,185 | $-32,544 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,761 | -48,206 | 8,980 | 26,117 | N/A |
| PPE Investments | -1,646 | -753 | -685 | -294 | N/A |
| Other Investing Activity | -705 | 0 | 25,607 | 0 | 0 |
| Investing Cash Flow | $-12,112 | $-48,959 | $33,902 | $25,823 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 90,000 | 0 | 30,000 | N/A | N/A |
| Debt Repayment | -24,344 | -6,775 | 0 | N/A | N/A |
| Common Stock Issued | 2,437 | 100,735 | 29 | 4 | N/A |
| Other Financing Activity | -5,354 | -6,044 | -2,942 | -948 | 0 |
| Financing Cash Flow | $62,739 | $87,916 | $27,087 | $-944 | $N/A |
| Beginning Cash Position | 40,302 | 48,544 | 23,740 | 31,405 | N/A |
| End Cash Position | 32,980 | 40,302 | 48,544 | 23,740 | N/A |
| Net Cash Flow | $-7,322 | $-8,242 | $24,804 | $-7,665 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -57,949 | -47,199 | -36,185 | -32,544 | N/A |
| Capital Expenditure | -1,646 | -753 | -685 | -294 | N/A |
| Free Cash Flow | -59,595 | -47,952 | -36,870 | -32,838 | 0 |